4.7 Article Proceedings Paper

Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study

期刊

EUROPEAN HEART JOURNAL
卷 27, 期 12, 页码 1408-1415

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehl040

关键词

chest pain; prognosis; women; myocardial ischaemia

资金

  1. NCRR NIH HHS [M01-RR00425] Funding Source: Medline
  2. NHLBI NIH HHS [U01 HL649141, U01 HL649241, N01-HV-68163, N01-HV-68162, N01-HV-68161, N01-HV-68164] Funding Source: Medline
  3. PHS HHS [U0164829] Funding Source: Medline

向作者/读者索取更多资源

Aims Women with chest pain but without obstructive coronary artery disease (CAD) are considered at low risk for cardiovascular (CV) events, but half continue to experience debilitating chest pain over many years. This study compared CV outcomes in women with persistent chest pain (PChP) vs. those without PChP Methods and results We studied 673 Women's Ischaemia Syndrome Evaluation (WISE) participants with chest pain undergoing coronary angiography for suspected myocardial ischaemia and at least 1 year of follow-up. PChP was defined as self-reported continuing chest pain after 1 year. Events occurring after that year were recorded for a median of 5.2 years. We compared CV event rates for women with and without PChP in subgroups with and without obstructive CAD. The median age was 58 years, 20% were racial minorities, 45% had PChP, 39% had obstructive CAD. Among women without CAD, those with PChP had more than twice the rate of composite CV events (P=0.03), that included non-fatal myocardial infarctions (P=0.11), strokes (P=0.03), congestive heart failure (P=0.38), and CV deaths (P=0.73), compared with those without PChP In women with CAD, there was no difference in composite CV events in those with and without PChP (P=0.72). Conclusion Among women undergoing coronary angiography for suspected myocardial ischaemia, PChP in women with no obstructive CAD predicted adverse CV outcomes. Such women might benefit from additional evaluation and aggressive risk factor modification therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据